Search Results - "Blind, Michael"

Refine Results
  1. 1

    Aptamer Selection Technology and Recent Advances by Blind, Michael, Blank, Michael

    Published in Molecular therapy. Nucleic acids (01-01-2015)
    “…Over the last decade, aptamers have begun to find their way from basic research to diverse commercial applications. The development of diagnostics is even more…”
    Get full text
    Journal Article
  2. 2

    Cytoplasmic RNA Modulators of an Inside-Out Signal-Transduction Cascade by Blind, Michael, Kolanus, Waldemar, Famulok, Michael

    “…A vaccinia virus-based RNA expression system enabled high-level cytoplasmic expression of RNA aptamers directed against the intracellular domain of the β 2…”
    Get full text
    Journal Article
  3. 3

    Controlling Small Guanine-Nucleotide-Exchange Factor Function through Cytoplasmic RNA Intramers by Mayer, Günter, Blind, Michael, Nagel, Wolfgang, Böhm, Thomas, Knorr, Thomas, Jackson, Catherine L., Kolanus, Waldemar, Famulok, Michael

    “…ADP-ribosylation factor (ARF) GTPases and their regulatory proteins have been implicated in the control of diverse biological functions. Two main classes of…”
    Get full text
    Journal Article
  4. 4

    Using aptamers as capture reagents in bead-based assay systems for diagnostics and hit identification by Porschewski, Peter, Grättinger, Mira A-M, Klenzke, Kerstin, Erpenbach, Anja, Blind, Michael R, Schäfer, Frank

    Published in Journal of biomolecular screening (01-10-2006)
    “…Most applications of xMAP (Luminex) bead-based assay technology in diagnostics and drug discovery use immobilized antigens or antibodies. Here the authors…”
    Get more information
    Journal Article
  5. 5

    Nucleic Acid AptamersFrom Selection in Vitro to Applications in Vivo by Famulok, Michael, Mayer, Günter, Blind, Michael

    Published in Accounts of chemical research (03-06-2000)
    “…Aptamers are nucleic acid ligands which are isolated from combinatorial oligonucleotide libraries by in vitro selection. They exhibit highly complex and…”
    Get full text
    Journal Article
  6. 6

    Aptamers as tools for target validation by Blank, Michael, Blind, Michael

    Published in Current opinion in chemical biology (01-08-2005)
    “…Synthetic nucleic acid ligands, called aptamers, bind to protein targets with high specificity and affinity. They are very potent inhibitors of protein…”
    Get full text
    Journal Article
  7. 7

    Selective Aptamer-Based Control of Intraneuronal Signaling by Lennarz, Sabine, Alich, Therese Christine, Kelly, Tony, Blind, Michael, Beck, Heinz, Mayer, Günter

    Published in Angewandte Chemie International Edition (27-04-2015)
    “…Cellular behavior is orchestrated by the complex interactions of a myriad of intracellular signal transduction pathways. To understand and investigate the role…”
    Get full text
    Journal Article
  8. 8

    Nucleic Acid AptamersFrom Selection in Vitro to Applications in Vivo by Famulok, Michael, Mayer, Günter, Blind, Michael

    Published in Accounts of chemical research (01-09-2000)
    “…Aptamers are nucleic acid ligands which are isolated from combinatorial oligonucleotide libraries by in vitro selection. They exhibit highly complex and…”
    Get full text
    Journal Article
  9. 9

    In vitro selection of RNA aptamers that inhibit the activity of type A botulinum neurotoxin by Chang, Tzuu-Wang, Blank, Michael, Janardhanan, Pavithra, Singh, Bal Ram, Mello, Charlene, Blind, Michael, Cai, Shuowei

    “…The category A agent, botulinum neurotoxin (BoNT), is the most toxic molecule known to mankind. The endopeptidase activity of light chain domain of BoNT is the…”
    Get full text
    Journal Article
  10. 10

    An Aptamer to the MAP Kinase Insert Region by Lennarz, Sabine, Heider, Elena, Blind, Michael, Mayer, Günter

    Published in ACS chemical biology (16-01-2015)
    “…Targeting functional, non-catalytic domains of protein kinases or other proteins is an emerging field in chemical biology research. Non-ATP competitive kinase…”
    Get full text
    Journal Article
  11. 11

    Positive Modulation of the Glycine Receptor by Means of Glycine Receptor-Binding Aptamers by Shalaly, Nancy Dekki, Aneiros, Eduardo, Blank, Michael, Mueller, Johan, Nyman, Eva, Blind, Michael, Dabrowski, Michael A, Andersson, Christin V, Sandberg, Kristian

    Published in Journal of biomolecular screening (01-10-2015)
    “…According to the gate control theory of pain, the glycine receptors (GlyRs) are putative targets for development of therapeutic analgesics. A possible approach…”
    Get more information
    Journal Article
  12. 12

    From selection to caged aptamers: Identification of light-dependent ssDNA aptamers targeting cytohesin by Mayer, Günter, Lohberger, Andrea, Butzen, Sabine, Pofahl, Monika, Blind, Michael, Heckel, Alexander

    Published in Bioorganic & medicinal chemistry letters (01-12-2009)
    “…Caged aptamers represent valuable tools for the spatiotemporal control of protein function by light. Here we describe a general route starting with the de novo…”
    Get full text
    Journal Article
  13. 13

    An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro by Mayer, Günter, Wulffen, Bernhard, Huber, Christian, Brockmann, Jörg, Flicke, Birgit, Neumann, Lars, Hafenbradl, Doris, Klebl, Bert M, Lohse, Martin J, Krasel, Cornelius, Blind, Michael

    Published in RNA (Cambridge) (01-03-2008)
    “…G-protein-coupled receptors are desensitized by a two-step process. In a first step, G-protein-coupled receptor kinases (GRKs) phosphorylate agonist-activated…”
    Get full text
    Journal Article
  14. 14

    RNA-Based Approach towards Small-Molecule Inhibitors by Mayer, Günter, Faulhammer, Dirk, Grättinger, Mira, Fessele, Sabine, Blind, Michael

    “…Apt for the job: The identification of low‐molecular‐weight protein inhibitors for functional studies as well as for the generation of lead drug compounds is…”
    Get full text
    Journal Article
  15. 15

    Aptamers as tools for target prioritization and lead identification by Burgstaller, Petra, Girod, Anne, Blind, Michael

    Published in Drug Discovery Today (15-12-2002)
    “…The increasing number of potential drug target candidates has driven the development of novel technologies designed to identify functionally important targets…”
    Get full text
    Book Review Journal Article
  16. 16
  17. 17

    Selective Aptamer-Based Control of Intraneuronal Signaling by Lennarz, Sabine, Alich, Therese Christine, Kelly, Tony, Blind, Michael, Beck, Heinz, Mayer, Günter

    Published in Angewandte Chemie (27-04-2015)
    “…Cellular behavior is orchestrated by the complex interactions of a myriad of intracellular signal transduction pathways. To understand and investigate the role…”
    Get full text
    Journal Article
  18. 18

    Microbodies by Schmoldt, Hans-Ulrich, Daneschdar, Matin, Kolmar, Harald, Blind, Michael

    “…Microbodies are novel pharmacophoric entities which are derived from naturally occurring cystine-knot microproteins. They provide extremely stable scaffolds…”
    Get more information
    Journal Article
  19. 19

    Aptamers that bind to the antibiotic moenomycin A by Schürer, Heike, Stembera, Katherina, Knoll, Dietmar, Mayer, Günter, Blind, Michael, Förster, Hans-Heinrich, Famulok, Michael, Welzel, Peter, Hahn, Ulrich

    Published in Bioorganic & medicinal chemistry (01-10-2001)
    “…Nuclease-resistant moenomycin-binding aptamers with dissociation constants in the range of 300 to 400 nM have been selected. Competition experiments have…”
    Get full text
    Journal Article
  20. 20